BioCity Nottingham, the UK's largest bioscience and healthcare innovation centre, appointed its first chief executive on Monday. Glenn Crocker, 39, joined from Ernst & Young, where he helped universities to spin off companies as head of the UK biotechnology practice. BioCity is operated by a consortium that includes the two local universities and is run from premises donated by chemical company BASF to Nottingham Trent University. Dr Crocker graduated in genetics from Nottingham University and gained a PhD in immunology at Oxford University.
Details:
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to 罢贬贰’蝉 university and college rankings analysis
Already registered or a current subscriber?
Please or to read this article.